Suppr超能文献

相似文献

1
Alloanti-c in a c-positive, JAL-positive patient.
Vox Sang. 2009 Apr;96(3):240-3. doi: 10.1111/j.1423-0410.2008.01135.x. Epub 2008 Dec 5.
3
Alloanti-c/ce in a c+ceAR/Ce patient suggests that the rare RHCE ceAR allele (ceAR) encodes a partial c antigen.
Transfusion. 2009 Nov;49(11):2406-11. doi: 10.1111/j.1537-2995.2009.02308.x. Epub 2009 Jul 14.
4
Molecular basis of the Rh antigen RH48 (JAL).
Vox Sang. 2009 Apr;96(3):234-9. doi: 10.1111/j.1423-0410.2008.01142.x. Epub 2008 Dec 12.
5
DIIIa and DIII Type 5 are encoded by the same allele and are associated with altered RHCE*ce alleles: clinical implications.
Transfusion. 2010 Jun;50(6):1303-11. doi: 10.1111/j.1537-2995.2009.02573.x. Epub 2010 Jan 15.
6
RHCE*ceCF encodes partial c and partial e but not CELO, an antigen antithetical to Crawford.
Transfusion. 2011 Jan;51(1):25-31. doi: 10.1111/j.1537-2995.2010.02764.x.
7
RHCE*ceAR encodes a partial c (RH4) antigen.
Immunohematology. 2010;26(2):57-9.
8
RHCE*ceTI encodes partial c and partial e and is often in cis to RHD*DIVa.
Transfusion. 2013 Apr;53(4):741-6. doi: 10.1111/j.1537-2995.2012.03800.x. Epub 2012 Jul 13.
9
The JAL antigen (RH48) is the result of a change in RHCE that encodes Arg114Trp.
Transfusion. 2009 Apr;49(4):725-32. doi: 10.1111/j.1537-2995.2008.02034.x. Epub 2008 Dec 23.
10
JAL (RH48) blood group antigen: serologic observations.
Transfusion. 2009 Apr;49(4):719-24. doi: 10.1111/j.1537-2995.2008.02025.x. Epub 2008 Dec 15.

引用本文的文献

1
Genotyping in Sickle Cell Disease Patients: The French Strategy.
Transfus Med Hemother. 2018 Jul;45(4):264-270. doi: 10.1159/000490858. Epub 2018 Jul 6.
2
RHCE*ceCF encodes partial c and partial e but not CELO, an antigen antithetical to Crawford.
Transfusion. 2011 Jan;51(1):25-31. doi: 10.1111/j.1537-2995.2010.02764.x.
3
RhCE protein variants in Southwestern Germany detected by serologic routine testing.
Transfusion. 2009 Sep;49(9):1793-802. doi: 10.1111/j.1537-2995.2009.02220.x. Epub 2009 May 18.
4
JAL (RH48) blood group antigen: serologic observations.
Transfusion. 2009 Apr;49(4):719-24. doi: 10.1111/j.1537-2995.2008.02025.x. Epub 2008 Dec 15.

本文引用的文献

1
JAL (RH48) blood group antigen: serologic observations.
Transfusion. 2009 Apr;49(4):719-24. doi: 10.1111/j.1537-2995.2008.02025.x. Epub 2008 Dec 15.
2
The JAL antigen (RH48) is the result of a change in RHCE that encodes Arg114Trp.
Transfusion. 2009 Apr;49(4):725-32. doi: 10.1111/j.1537-2995.2008.02034.x. Epub 2008 Dec 23.
3
Molecular basis of the LOCR (Rh55) antigen.
Transfusion. 2006 Oct;46(10):1689-92. doi: 10.1111/j.1537-2995.2006.00968.x.
4
A "NEW" RH ANTIBODY (ANTI-RH 26) WHICH DETECTS A FACTOR USUALLY ACCOMPANYING HR'.
Transfusion. 1964 Nov-Dec;4:414-8. doi: 10.1111/j.1537-2995.1964.tb02900.x.
5
Rare RHCE phenotypes in black individuals of Afro-Caribbean origin: identification and transfusion safety.
Blood. 2002 Dec 1;100(12):4223-31. doi: 10.1182/blood-2002-01-0229. Epub 2002 Aug 1.
6
Involvement of Gly96 in the formation of the Rh26 epitope.
Transfusion. 1997 Nov-Dec;37(11-12):1123-30. doi: 10.1046/j.1537-2995.1997.37111298088040.x.
7
A low-incidence red cell antigen JAL associated with two unusual Rh gene complexes.
Vox Sang. 1990;59(1):39-43. doi: 10.1111/j.1423-0410.1990.tb02112.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验